u-PAR expression in cancer associated fibroblast: new acquisitions in multiple myeloma progression-Reference-Cited by-同舟云学术

u-PAR expression in cancer associated fibroblast: new acquisitions in multiple myeloma progression

Published:2017-03-24 Issue:1 Volume:17 Page:
ISSN:1471-2407
Container-title:BMC Cancer
language:en
Short-container-title:BMC Cancer

Author:

Ciavarella S,Laurenzana A,De Summa S,Pilato B,Chillà A,Lacalamita R,Minoia C,Margheri F,Iacobazzi A,Rana A,Merchionne F,Fibbi G,Del Rosso M,Guarini A,Tommasi S,Serratì S

Funder

Ministero della Salute

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Genetics,Oncology

Link

http://link.springer.com/content/pdf/10.1186/s12885-017-3183-y.pdf

Reference25 articles.

1. Hideshima T, Mitsiades C, Tonon G, Richardson PG, Anderson KC. Understanding multiple myeloma pathogenesis in the bone marrow to identify new therapeutic targets. Nat Rev Cancer. 2007;7(8):585–98.

2. Bianchi G, Munshi NC. Pathogenesis beyond the cancer clone(s) in multiple myeloma. Blood. 2015;125(20):3049–58.

3. Frassanito MA, Rao L, Moschetta M, Ria R, Di Marzo L, De Luisi A, Racanelli V, Catacchio I, Berardi S, Basile A, et al. Bone marrow fibroblasts parallel multiple myeloma progression in patients and mice: in vitro and in vivo studies. Leukemia. 2014;28(4):904–16.

4. Raffaghello L, Vacca A, Pistoia V, Ribatti D. Cancer associated fibroblasts in hematological malignancies. Oncotarget. 2015;6(5):2589–603.

5. Ghobrial IM. Myeloma as a model for the process of metastasis: implications for therapy. Blood. 2012;120(1):20–30.

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advances in nano-immunotherapy for hematological malignancies;Experimental Hematology & Oncology;2024-05-25

2. Epistemology of the Origin of Cancer II: Fibroblasts Are the First Cells to Undergo Neoplastic Transformation;Cellular Physiology and Biochemistry;2023-12-27

3. Circulating extracellular vesicles are monitoring biomarkers of anti-PD1 response and enhancer of tumor progression and immunosuppression in metastatic melanoma;Journal of Experimental & Clinical Cancer Research;2023-09-28

4. Cancer-associated fibroblasts in hematologic malignancies: elucidating roles and spotlighting therapeutic targets;Frontiers in Oncology;2023-09-06

5. Immunosuppressive MFAP2+ cancer associated fibroblasts conferred unfavorable prognosis and therapeutic resistance in gastric cancer;Cellular Oncology;2023-08-04